Kazia Therapeutics (KZIA) EPS (Basic) (2009 - 2017)
Kazia Therapeutics' (KZIA) quarterly EPS (Basic) came in at -$0.86 in Q2 2017, up 18.69% YoY from -$0.72 in Q2 2016, and up 65.72% on a QoQ basis from -$2.5 in Q4 2016.
Kazia Therapeutics (KZIA) EPS (Basic) (2009 - 2017) Analysis & Trends
Kazia Therapeutics (KZIA) has 9 years of EPS (Basic) data on file, last reported at -$0.86 in Q2 2017.
- Quarterly EPS (Basic) rose 18.69% year-over-year to -$0.86 in Q2 2017, while the trailing twelve-month figure through Dec 2018 was -$8.28 (up 69.28% YoY) and the FY2025 annual result came in at -$0.03, up 99.15% from the prior year.
- EPS (Basic) improved to -$0.86 in Q2 2017, from -$2.5 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.86 in Q2 2017 to a low of -$3.3 million in Q4 2013.
- A 5-year average of -$554983.8 and a median of -$2.0 in 2015 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2014 — EPS (Basic) soared 100.0% — and 2016, when it plunged 65.43%.
- Tracing KZIA's EPS (Basic) over 5 years: stood at -$3.3 million in 2013, then soared by 100.0% to -$4.53 in 2014, then surged by 66.64% to -$1.51 in 2015, then sank by 65.43% to -$2.5 in 2016, then surged by 65.72% to -$0.86 in 2017.
- The last three EPS (Basic) figures came in at -$0.86 (Q2 2017), -$2.5 (Q4 2016), and -$1.05 (Q2 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Kazia Therapeutics | 4.22 Bn | 4.22 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -0.86 |
| Dec 31, 2016 | -2.50 |
| Jun 30, 2016 | -1.05 |
| Dec 31, 2015 | -1.51 |
| Dec 31, 2014 | -4.53 |
| Dec 31, 2013 | -3.33 Mn |
| Oct 8, 2012 | -13.93 |
| Dec 31, 2011 | -1.14 |
| Dec 31, 2010 | -1.32 |
| Nov 26, 2009 | -1.46 |
| Aug 25, 2009 | -1.33 |